You just read:

Precigen Receives FDA Orphan Drug Designation for PRGN-3006 UltraCAR-T™ in Patients with Acute Myeloid Leukemia (AML)

News provided by

Precigen, Inc.

Jan 06, 2020, 07:30 ET